Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Congress is seeking insight from meteorologists and weather researchers on how new technology can enhance safety and response times to severe weather and prevent future disasters.
Labor Secretary Lori Chavez-DeRemer says the labor program will now be fully under her department, and consolidation will make the program more affordable and efficient for farmers and ranchers.
“We’re living in a moment of massive change—in agriculture, in media, and in leadership . . .”
Seth Boffeli, AARP Fraud Watch Network Senior Advisor, brings us a preview of tonight’s “RURAL AMERICA LIVE with AARP,” which will focus on tips for fighting fraud.
